PARLIAMENTARY EARLY DAY MOTION
PRESCRIPTION MEDICATION (16 May 2005)

That this House believes that consumers have a right to expect full and impartial information about the potential risks and side-effects of prescription medication; further believes that this requires a robust regulatory framework to ensure that information is not only publicly available but also acted upon promptly; and, in the light of continuing consumer disquiet about Seroxat and similar concerns about other medicines, calls for an urgent, full, independent and open review of the UK drug regulatory system.

Sponsored by:
Mr Mike Hancock (Independent)